Description

• Title:
  Critical Analysis of the Efficacy and Limitations of GLP-1 Pharmaceuticals in Obesity Management: A Comprehensive Literature Review
• Creator:
  Gierlach, Katarzyna;
  Nowak, Karolina;
  Olejarz, Zuzanna;
  Słowik, Magdalena;
  Drygała, Zuzanna;
  Wyrwał, Julia;
  Zielińska, Zuzanna;
  Nieć, Maria;
  Krasuska, Martyna
• Description:
  Introduction and purpose Obesity, a pervasive global pandemic intricately linked to various comorbidities, necessitates a comprehensive and nuanced approach. This article delves into the intricate realm of obesity guidelines, underscoring the significance of lifestyle modifications, preventive measures for childhood obesity, population-based strategies, clinical management protocols, and vigilant monitoring. GLP-1 drugs, originally designed for type 2 diabetes management, exhibit multifaceted effects beyond glycemic control. They influence appetite regulation, gastric emptying dynamics, and potentially contribute to cardiovascular health improvements. However, the commendable effects come with a caveat - potential side effects necessitating careful consideration in clinical decision-making. Despite gaining popularity through celebrity endorsements, this article firmly underscores the need to view GLP-1 pharmacotherapy as a recommended intervention rather than a miraculous solution. A brief description of the state of knowledge Integral to the obesity discourse is the imperative to address weight stigma, demanding evidence-based approaches in both clinical and public health domains. The narrative extends into the future landscape of obesity pharmacotherapy, contemplating the potential role of probiotics. Emphasizing the necessity for long-term studies and randomized trials, it positions probiotics as a low-risk alternative with significant potential in mitigating obesity while simultaneously addressing concerns related to antibiotic resistance. Summary The pursuit of a balanced and effective approach to obesity management necessitates a nuanced understanding of medical interventions, consideration of societal perceptions, and exploration of innovative possibilities within the evolving landscape of healthcare.
• Object availability:
  free access
• Rights: https://creativecommons.org/licenses/by-nc-sa/4.0 ;
  Prawa autorskie (c) 2024 Katarzyna Gierlach, Karolina Nowak, Karolina Nowak, Zuzanna Olejarz, Magdalena Słowik, Zuzanna Drygała, Julia Wyrwał, Zuzanna Zielińska, Maria Nieć, Martyna Krasuska
• Date:
  2024.01.26
• Type:
  info:eu-repo/semantics/article;
  info:eu-repo/semantics/publishedVersion
• Language:
  English
• Source:
  Journal of Education, Health and Sport; Vol. 55 (2024); 87-103;
  Journal of Education, Health and Sport; Tom 55 (2024); 87-103;
  2391-8306
• Format:
  application/pdf
• Publisher:
  Nicolaus Copernicus University, Toruń, Poland
• Relation: https://apcz.umk.pl/JEHS/article/view/47937/37488
• Subject:
  Obesity;
  Diabetes;
  Pharmacotherapy;
  Prevention;
  GLP-1;
  Epidemiology
• Identifier: https://apcz.umk.pl/JEHS/article/view/47937
• Data provider:
  Akademicka Platforma Czasopism
• Can I use it?:
  seek permission
• Type:
  text